Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Myokardia Inc (MYOK)

$45.79 0.68 (1.46%)

17:46 EDT MYOK Stock Quote Delayed 15 Minutes

Volume:

Previous Close $45.79

Market Cap 1.65B

PE Ratio -32.02

EPS -1.43

Volume (Avg. Vol.) 236,200

Day's Range 45.65 - 47.56

52-Week Range 39.01 - 67.79

Dividend & Yield N/A (N/A)

MYOK Stock Predictions, Articles, and Myokardia Inc News

From the Web

Best & Worst Performing Mid Cap Stocks for June 21, 2019

From StockNews.com Jun 21, 2019

PBF – PBF leads the way today as the best performing mid cap stock, closing up 11.28%.

Best & Worst Performing Mid Cap Stocks for June 17, 2019

From StockNews.com Jun 17, 2019

BID – BID leads the way today as the best performing mid cap stock, closing up 58.60%.

Best & Worst Performing Mid Cap Stocks for June 11, 2019

From StockNews.com Jun 11, 2019

<p><strong><a href="/stock/PAM/">PAM</a></strong> – PAM leads the way today as the best performing mid cap stock, closing up 10.91%.</p>

Best & Worst Performing Mid Cap Stocks for June 6, 2019

From StockNews.com Jun 6, 2019

<p><strong><a href="/stock/CIEN/">CIEN</a></strong> – CIEN leads the way today as the best performing mid cap stock, closing up 26.78%.</p>

Best & Worst Performing Mid Cap Stocks for May 30, 2019

From StockNews.com May 30, 2019

<p><strong><a href="/stock/DOOO/">DOOO</a></strong> – DOOO leads the way today as the best performing mid cap stock, closing up 15.56%.</p>

Myovant launches $100M stock offering; shares down 8% after hours

From Seeking Alpha May 29, 2019

Myovant Sciences (NASDAQ:MYOK) is off 8% after hours in response to its $100M public offering of common stock. Price, volume and terms have yet to be released.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!